Cardiol Therapeutics Inc. (CRDL) income statement
CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.86−0.02 (-2.28%)
Close on Nov 20, 2026Market cap $86.48MP/E –Yield –
Cardiol Therapeutics Inc. financial ratios
See a number that looks wrong?